Applied DNA Secures 1-Year Contract Extension with Defense Logistics Agency (DLA) for DNA-marking with SigNature® DNA
November 20 2017 - 5:30AM
Business Wire
Extends Uninterrupted Support for FSC 5962
Microcircuits
Applied DNA Sciences, Inc. (NASDAQ: APDN; “Applied DNA”) today
announced that the Defense Logistics Agency (DLA) has awarded the
Company a one-year extension of its current contract through
October 13, 2018. This agreement maintains consistent support of
the DNA marking lab originally established December 2014 at DLA’s
Land and Maritime facility in Columbus, OH. With a focus on Federal
Supply Class 5962 microcircuits, Applied DNA provides DLA’s
Electronic Product Test Center (PTC) with full support including
creation of SigNature® DNA marks, related equipment and supplies,
services and continuous improvement.
“My team and I are proud to be part of Land and Maritime’s
strategic initiative to identify and manage supply-system risks
with the use of innovative DNA technology that can be inserted into
DLA acquisition programs to meet specific defense needs. To date,
over 800,000 microcircuits have been DNA marked,” stated Janice
Meraglia, vice president of Government and Military Programs at
Applied DNA. “It is an honor to continue to work with the PTC team
in Columbus to keep our Warfighters safe.”
About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable
supply chain security, anti-counterfeiting and anti-theft
technology, product genotyping and DNA mass production for
diagnostics and therapeutics.
We make life real and safe by providing innovative,
molecular-based technology solutions and services that can help
protect products, brands, entire supply chains, and intellectual
property of companies, governments and consumers from theft,
counterfeiting, fraud and diversion. The proprietary DNA-based
“CertainT®” platform can be used to identify, tag, test, and track
products, to help assure authenticity, origin, traceability,
sustainability and quality of products.
SigNature® DNA describes the core technology ingredient that is
at the heart of a family of uncopyable, security and authentication
solutions such as SigNature® T and fiberTyping®, targeted toward
textiles and apparel, BackTrac® and DNAnet®, for anti-theft and
loss prevention, and digitalDNA®, providing powerful
track-and-trace. All provide a forensic chain of evidence, and can
be used to prosecute perpetrators. Applied DNA Sciences is also
engaged in the large-scale production of specific DNA sequences
using the polymerase chain reaction.
Visit adnas.com for more information. Follow us on Twitter and
LinkedIn. Join our mailing list.
The Company’s common stock is listed on NASDAQ under the symbol
APDN, and its warrants are listed under the symbol APDNW.
Forward Looking Statements
The statements made by APDN in this press release may be
“forward-looking” in nature within the meaning of the Private
Securities Litigation Act of 1995. Forward-looking statements
describe APDN’s future plans, projections, strategies and
expectations, and are based on assumptions and involve a number of
risks and uncertainties, many of which are beyond the control of
APDN. Actual results could differ materially from those projected
due to our short operating history, limited financial resources,
limited market acceptance, market competition and various other
factors detailed from time to time in APDN’s SEC reports and
filings, including our Annual Report on Form 10-K filed on December
6, 2016, and our subsequent quarterly reports on Form 10-Q filed on
February 9, 2017, May 11, 2017 and August 10, 2017, which are
available at www.sec.gov. APDN undertakes no obligation to update
publicly any forward-looking statements to reflect new information,
events or circumstances after the date hereof to reflect the
occurrence of unanticipated events, unless otherwise required by
law.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171120005262/en/
For Applied DNA Sciences, Inc.Investors:LHA Investor
RelationsSanjay M. Hurry,
212-838-3777shurry@lhai.comorMedia:Dian Griesel Int’lCheryl
Schneider,
212-825-3210cschneider@dgicomm.comorProgram:Janice Meraglia,
631-240-8821janice.meraglia@adnas.comweb: www.adnas.com |
twitter: @APDN
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Apr 2023 to Apr 2024